BioSpace News Archive

Each October, INC Magazine chooses leading women pioneers, entrepreneurs and innovators to profile in its annual Women Entrepreneurs issue.

EAS Consulting Group is honored to announce that Dean Cirotta, EAS President and COO, was an invited key speaker to the September 29, 2018 Fourth Session of the SIDS DOCK Assembly

PURE Bioscience (OTCQB: PURE), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, announced today that Tom Myers has been promoted to Chief Operating Officer.

BioTrackTHC, a wholly-owned subsidiary of Helix TCS, Inc (OTCQB: HLIX) joins fellow industry leaders as a sponsor of the fourth annual New West Summit, a conference that zeroes in on the game-changing, disruptive developments in technology, science, media and investment within the cannabis space

Celebrating its 8th anniversary, the 2018 IEEE Global Humanitarian Technology Conference (GHTC) is a world class conference focused on discussing sustainable development and humanitarian technology related policy, insight and experiences and showcasing activities aligned with United Nations Sustainable Development Goals (UN SDGs). Today, IEEE GHTC 2018 announces keynote speakers and program highlights.

The V Foundation for Cancer Research and Parker Institute for Cancer Immunotherapy Join as Sponsors

Longeveron, a biopharmaceutical company that develops stem cell therapies, announced that Co-Founder and Chief Science Officer Joshua Hare, M.D. will be a keynote speaker at the 2018 HEALinc Future Health Innovation Summit, to be held Oct. 7-9 at the Melia Nassau Beach Hotel, Nassau, Bahamas.

Michaeline Daboul, MediSpend’s CEO & President, will moderate a panel of life sciences industry experts as they discuss the challenges and opportunities surrounding the governance of HCP engagements. The panel will discuss this important topic at CBI’s 2nd Annual Comprehensive Strategies for Managing HCP Interactions Conference at 2:45pm on Wednesday, October 10, 2018 in Philadelphia, PA.

Recommendations are detailed in new roadmaps (algorithms) outlining therapies and medications to help achieve optimal diabetes control and improved quality of life

Promethera Biosciences SA today announced that Mutsuki Takano, currently Branch General Manager of Promethera Biosciences Japan Branch and Member of the Management Team of Promethera Biosciences SA will succeed Frank Hazevoets as Group Chief Financial Officer (Group CFO), in addition to his current responsibilities.